This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies
September 18-19, 2024
Omni Boston Hotel at the SeaportBoston, MA

Michael Thater
Corporate Controller at Entrada Therapeutics


Michael Thater serves as Executive Director, Controller at Entrada Therapeutics (NASDAQ: TRDA). Michael joined Entrada in 2020 as the first finance hire and played a key role in the Company going public in late 2021. At Entrada he developed and oversees the processes related to Accounting, SEC reporting, Treasury, Tax, SOX404, AP, and Payroll. Prior to Entrada, Michael held positions at another start-up biotech as well as a publicly traded asset manager and started his accounting and finance career at EY where he was a manager in the assurance practice. He is a CPA and has his MBA from D’Amore-McKim School of Business at Northeastern and his B.A. from Holy Cross.

Agenda Sessions

  • Scaling for Growth: Architectural Development Benefitting Companies as they Mature